Search research articles
Contact Us
Filters
Showing results (211-220 of 312) with videos related to
Page
of 32
Sort By:
Genetics in Medicine Open
|
August 18, 2025
Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1
Niamh X Cawley, Ruyu Zhou, Avani Mylvara, et al.
Journal of Neurodevelopmental Disorders
|
June 30, 2010
Aging in fragile X syndrome
Agustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Frontiers in Genetics
|
June 6, 2018
Health Profiles of Mosaic Versus Non-mosaic <i>FMR1</i> Premutation Carrier Mothers of Children With Fragile X Syndrome
Marsha R Mailick, Arezoo Movaghar, Jinkuk Hong, et al.
American Journal of Medical Genetics. Part A
|
December 8, 2006
Neuropathic features in fragile X premutation carriers
Elizabeth Berry-Kravis, Christopher G Goetz, Maureen A Leehey, et al.
Pediatrics
|
January 2, 2009
Advances in the treatment of fragile X syndrome
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Neurodevelopmental Disorders
|
November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Sciences
|
December 19, 2018
Best Practices in Fragile X Syndrome Treatment Development
Craig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders
|
January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome
Kathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Neurology
|
February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disability
Rebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Journal of Child and Adolescent Psychopharmacology
|
February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity
Lindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Page
of 32
Search research articles
Search
Showing results (211-220 of 312) with videos related to
Sort By:
Page
of 32
Genetics in Medicine Open
|
August 18, 2025
Serum neurofilament light protein as a biomarker in Niemann-Pick disease, type C1
Niamh X Cawley, Ruyu Zhou, Avani Mylvara, et al.
Journal of Neurodevelopmental Disorders
|
June 30, 2010
Aging in fragile X syndrome
Agustini Utari, Evan Adams, Elizabeth Berry-Kravis, et al.
Frontiers in Genetics
|
June 6, 2018
Health Profiles of Mosaic Versus Non-mosaic <i>FMR1</i> Premutation Carrier Mothers of Children With Fragile X Syndrome
Marsha R Mailick, Arezoo Movaghar, Jinkuk Hong, et al.
American Journal of Medical Genetics. Part A
|
December 8, 2006
Neuropathic features in fragile X premutation carriers
Elizabeth Berry-Kravis, Christopher G Goetz, Maureen A Leehey, et al.
Pediatrics
|
January 2, 2009
Advances in the treatment of fragile X syndrome
Randi J Hagerman, Elizabeth Berry-Kravis, Walter E Kaufmann, et al.
Journal of Neurodevelopmental Disorders
|
November 26, 2022
A randomized, controlled trial of ZYN002 cannabidiol transdermal gel in children and adolescents with fragile X syndrome (CONNECT-FX)
Elizabeth Berry-Kravis, Randi Hagerman, Dejan Budimirovic, et al.
Brain Sciences
|
December 19, 2018
Best Practices in Fragile X Syndrome Treatment Development
Craig A Erickson, Walter E Kaufmann, Dejan B Budimirovic, et al.
Journal of Neurodevelopmental Disorders
|
January 25, 2025
A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome
Kathleen Campbell, Jeffrey L Neul, David N Lieberman, et al.
Neurology
|
February 26, 2020
Validation of the NIH Toolbox Cognitive Battery in intellectual disability
Rebecca H Shields, Aaron J Kaat, Forrest J McKenzie, et al.
Journal of Child and Adolescent Psychopharmacology
|
February 6, 2025
The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity
Lindsay M Oberman, Elizabeth Berry-Kravis, Dejan B Budimirovic, et al.
Page
of 32